Scarica l'app Stockscreener
1.46
2.82%
0.04
Dopo l'orario di chiusura:
1.49
0.03
+2.05%
Co Diagnostics Inc Borsa (CODX) Ultime notizie
Tuberculosis test heads to Washington summit as Co-Diagnostics joins TB push - Stock Titan
Co-Diagnostics (CODX) price target decreased by 20.00% to 30.60 - MSN
Co-Diagnostics (CODX) price target decreased by 37.50% to 1.28 - MSN
Co-Diagnostics to show new PCR platform at Munich infection meeting - Stock Titan
Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany - Bitget
symbol__ Stock Quote Price and Forecast - CNN
Investment Review: What analysts say about Co Diagnostics Inc stockProfit Target & Daily Volume Surge Trade Alerts - baoquankhu1.vn
CODX Technical Analysis | Trend, Signals & Chart Patterns | CO-DIAGNOSTICS INC (NASDAQ:CODX) - ChartMill
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah - BioSpace
Co-Diagnostics Executives to Participate in European Trade Missi - GuruFocus
Portfolio Update: Is Co Diagnostics Inc benefiting from interest rate changesMarket Movement Recap & Low Risk High Reward Ideas - baoquankhu1.vn
Aug Drivers: Can Co Diagnostics Inc scale operations efficientlyWatch List & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Bull Bear: What analysts say about Co Diagnostics Inc stockTrade Risk Assessment & Real-Time Stock Entry Alerts - baoquankhu1.vn
COVID-19 Detection Kits Market Set to Boom Rapidly by 2033 | - openPR.com
Co-Diagnostics Q4 2025 earnings preview - MSN
Co-Diagnostics, Inc. (CODX) stock price, news, quote and history - uk.finance.yahoo.com
Co-Diagnostics Earnings Call: Pipeline Progress, Cash Strain - TipRanks
Q4 2025 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
Co-Diagnostics Joint Venture to Build Molecular Diagnostics Facility in Saudi Arabia - Clinical Lab Products
Co-Diagnostics Joint Venture Comira Receives Approval For Manufacturing Facility In Kingdom Of Saudi Arabia's Sudair Industrial City - TradingView — Track All Markets
Co-Diagnostics, Inc.'s joint venture Comira has officially received approval to establish a manufacturing facility in Sudair Industrial City, Kingdom of Saudi Arabia. - Bitget
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City - The Herald Journal
Co-Diagnostics reports operating loss of USD 50.2M in 2025 - Medical Buyer
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2025 Earnings Call Transcript - Insider Monkey
This diagnostics company is advancing a global expansion strategy, positioning for growth phase - MSN
Co-Diagnostics Expands South Asia Footprint, Targeting $13B Diagnostics Opportunity - USA Today
Exclusive: Co-Diagnostics ships diagnostic tests to India ahead of TB study launch - MSN
Co-Diagnostics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Stra - gurufocus.com
Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... By GuruFocus - Investing.com Canada
Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... - Yahoo Finance
Co-Diagnostics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Co-Diagnostics Q4 2025 sees mixed results, stock up 12% - Investing.com India
Co-Diagnostics Reports Full Year 2025 Financial Results - GuruFocus
Earnings call transcript: Co-Diagnostics Q4 2025 sees mixed results, stock up 12% By Investing.com - Investing.com South Africa
CODX: Revenue fell, losses widened, but global expansion and regulatory progress drive future growth - TradingView — Track All Markets
This Diagnostics Company Is Advancing a Global Expansion Strategy, Positioning for Growth Phase - The Globe and Mail
CODX: Revenue fell, but global expansion and clinical progress set the stage for future growth - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Co-Diagnostics (CODX) Releases Q4 2025 Earnings: Revenue Down, Net Loss Widens - Quiver Quantitative
Co-Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Co-Diagnostics (NASDAQ: CODX) warns on going concern while advancing PCR platform - Stock Titan
Co-Diagnostics (NASDAQ: CODX) 2025 revenue plunges as cash declines - Stock Titan
Press Release: Co-Diagnostics Reports Full Year 2025 Financial Results - 富途牛牛
Co-Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Exclusive: Co-Diagnostics expands South Asia reach, targets $13 billion market opportunity - msn.com
FRA:C970 PB Ratio: 0.24 — 86% Below Median - GuruFocus
Co-Diagnostics Inc expected to post a loss of $3.60 a shareEarnings Preview - TradingView
0.62%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):